Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel in Infants with Cyanotic Congenital Heart Disease (CLARINET)
NCT00396877Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2006
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of clopidogrel in cyanotic congenital heart disease (CCHD), sponsored by Sanofi. Started Nov 2006; status: completed.
02
Drugs
clopidogrel
03
Conditions
cyanotic congenital heart disease (CCHD)
Beyond the preview
Go deeper on NCT00396877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396877.